Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/INO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Inovio Pharmaceuticals Inc (INO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Inovio Pharmaceuticals trades at $1.01, up 2.01% today, with a bearish technical signal despite recent earnings beats. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses of $84.95 million in 2025. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, with analyst consensus at Buy (58.83%) and $2.75 price target suggesting 172% upside potential.
The investment case hinges on FDA approval of INO-3107, offering substantial upside if successful. However, persistent cash burn, negative margins, and reliance on financing create high risk. Current valuation metrics appear disconnected from fundamentals, making this suitable only for risk-tolerant investors betting on binary regulatory outcomes.
Read full analysis

Key Stats

  • Market Cap
    $103.40M
  • Volume
    2,094,834
  • Sector
    Health
  • 52W High
    $2.60
  • 52W Low
    $0.66
  • Typical Hold Time
    43 Days
  • Enterprise Value
    $74.73M
  • Div Yield
    -
  • Trading Activity
    100% Sell | 0% Buy
$1.06
52W Low: $0.66
30 Jul 2026
52W High: $2.6
17 Dec 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.6, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Most Recent News

Content is generated by Aura AI

Anthropic proposes AI safety bill to block risky AI models causing death or billion-dollar damage

Anthropic has drafted a new AI safety bill proposing government regulation to block AI models that pose "foreseeable, imminent risks" such as causing over 50 deaths or a billion dollars in property damage. The bill suggests using independent evaluato...

Market News
4 hours ago
TechCrunch
Neutral
Anthropic proposes AI safety bill to block risky AI models causing death or billion-dollar damage

SpaceX and Tesla boards form special committees to explore a possible merger, says Elon Musk.

SpaceX and Tesla have each established special committees composed of independent directors to review a potential merger, initiated at the request of shareholders. Elon Musk, CEO and major shareholder of both companies, supports the idea but notes it...

Market News
4 hours ago
TechCrunch
Neutral
SpaceX and Tesla boards form special committees to explore a possible merger, says Elon Musk.

Law firm investigates fairness of mergers for Utz, Safety Insurance, Passage Bio, and Finward shareholders.

Monteverde & Associates PC is investigating the fairness of merger deals involving Utz Brands, Safety Insurance Group, Passage Bio, and Finward Bancorp. Shareholders of these companies are offered specific cash or stock deals, and the firm is assessi...

Market News
4 hours ago
GlobeNewsWire
Neutral
Law firm investigates fairness of mergers for Utz, Safety Insurance, Passage Bio, and Finward shareholders.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $103.40M
  • Volume
    2,094,834
  • Sector
    Health
  • 52W High
    $2.60
  • 52W Low
    $0.66
  • Typical Hold Time
    43 Days
  • Enterprise Value
    $74.73M
  • Div Yield
    -
  • Trading Activity
    100% Sell | 0% Buy
$1.06
52W Low: $0.66
30 Jul 2026
52W High: $2.6
17 Dec 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.6, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!